GlassScriptPhysician profile
Chad Rosen
NPI 1588999148
$34,354.28
in general payments reported to CMS, 2019-2025
12 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,103 · 2020: $11K · 2021: $5,800 · 2022: $5,276 · 2023: $4,784 · 2024: $637 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,500 · Gift: $1,320 · Food and Beverage: $666 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250 · Travel and Lodging: $4.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,500.00 |
| Gift | $1,320.00 |
| Food and Beverage | $666.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250.00 |
| Travel and Lodging | $4.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $12,469.67 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11,000.00 | 2019-2021 | |
| Visionary Optics LLC | $9,119.40 | 2022-2023 | |
| Alcon Vision LLC | $494.47 | 2019-2025 | Air Optix, Total30 |
| Johnson & Johnson Vision Care, INC. | $450.00 | 2019-2025 | Acuvue |
| The Walman Optical Company | $270.00 | 2024 | Boston Xo2 |
| Valley Contax, INC. | $200.00 | 2020 | |
| Glaukos Corporation | $123.76 | 2023-2024 | Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Tarsus Pharmaceuticals, INC. | $77.09 | 2025 | Xdemvy |
| Integra Lifesciences Corporation | $68.00 | 2022 | |
| Abbvie INC. | $43.19 | 2022-2023 | |
| Biotissue Holdings INC. | $38.70 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.